It is a research-use-only reference material, not an approved medicine
It brings together GLP-1 dosing, side effects, weight, and key Oura signals (sleep, activity, readiness, and stress) into a single, longitudinal view so you can see how your treatment and daily habits are working together over time
Reduction of Inflammation and Visceral Fat By reducing inflammatory cytokines and visceral fat, Tesamorelin indirectly supports systemic recovery and overall metabolic health
Retatrutide is investigational and not approved for human use
However, it does not reverse androgenetic alopecia on its own
A: Two ways that body composition changes during GLP-1 use include: Lean Muscle Loss - Research indicates lean body mass reduction of 39% of total weight lost